Vivimed Labs (NSE:VIVIMEDLAB) Shiller PE Ratio: (As of Aug. 29, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:VIVIMEDLAB Vivimed Labs Ltd NSE:VIVIMEDLAB
35 GF Score
Price ₹7.07
GF Value ₹2.41
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Vivimed Labs Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Vivimed Labs  (NSE:VIVIMEDLAB) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Vivimed Labs Shiller PE Ratio Related Terms


Vivimed Labs Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Vivimed Labs's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vivimed Labs Shiller PE Ratio Chart

Vivimed Labs Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.64 1.90 2.89 0.00 0.00

Vivimed Labs Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NSE:VIVIMEDLAB vs ZTS: Shiller PE Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vivimed Labs's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vivimed Labs Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vivimed Labs's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Vivimed Labs's Shiller PE Ratio falls into.


NSE:VIVIMEDLAB
35GF Score
Vivimed Labs Ltd NSE:VIVIMEDLAB
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vivimed Labs Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Vivimed Labs's E10 for the quarter that ended in Mar. 2026 is calculated as:

For example, Vivimed Labs's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-17.74/164.2724*164.2724
=-17.740

Current CPI (Mar. 2026) = 164.2724.

Vivimed Labs Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201606 3.310 105.961 5.132
201609 3.220 105.961 4.992
201612 6.190 105.196 9.666
201703 12.810 105.196 20.004
201706 2.860 107.109 4.386
201709 2.692 109.021 4.056
201712 2.500 109.404 3.754
201803 1.070 109.786 1.601
201806 3.310 111.317 4.885
201809 2.120 115.142 3.025
201812 1.260 115.142 1.798
201903 -0.030 118.202 -0.042
201906 1.190 120.880 1.617
201909 -3.180 123.175 -4.241
201912 -3.870 126.235 -5.036
202003 -7.340 124.705 -9.669
202006 1.500 127.000 1.940
202009 -1.640 130.118 -2.070
202012 -5.980 130.889 -7.505
202103 -3.310 131.771 -4.126
202106 -0.280 134.084 -0.343
202109 -2.810 135.847 -3.398
202112 -0.290 138.161 -0.345
202203 -2.211 138.822 -2.616
202206 -2.680 142.347 -3.093
202209 -2.660 144.661 -3.021
202212 -2.210 145.763 -2.491
202303 -32.080 146.865 -35.882
202306 -1.880 150.280 -2.055
202309 -2.450 151.492 -2.657
202312 -1.940 152.924 -2.084
202403 0.640 153.035 0.687
202406 -1.840 155.789 -1.940
202409 -0.620 157.882 -0.645
202412 -0.720 158.323 -0.747
202503 -0.680 157.552 -0.709
202506 -0.660 159.755 -0.679
202509 -0.880 162.289 -0.891
202512 -2.000 163.281 -2.012
202603 -17.740 164.272 -17.740

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Vivimed Labs (NSE:VIVIMEDLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Vivimed Labs stock appears to be overvalued. The current stock price of ₹7.07 is trading 193.4% above its estimated GF Value™ of ₹2.41. GuruFocus considers Vivimed Labs to be Significantly Overvalued.

Key valuation signals for NSE:VIVIMEDLAB:

  • Shiller PE Ratio:
  • GF Value™: ₹2.41 vs. price of ₹7.07 (193.4% above fair value)
  • GF Score™: 35/100 with 6 warning signs

No single metric tells the full story. See the NSE:VIVIMEDLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vivimed Labs Business Description

Other Exchanges 532660:India
Address Green Lands, Beside The Plaza Hotel, D.No. 6-3-866/1/G1, 3rd & 4th Floor, GMR Towers, Begumpet, Hyderabad, TG, IND, 500016
Vivimed Labs Ltd is an India-based company that is engaged in the Business of Active pharmaceutical ingredients, Intermediates, Nutraceutical ingredients, CDMO Finished Dosage Formulation, Specialty Chemicals, and Retail Branded Formulation manufacturing. The company has three reportable segments: the Speciality Chemicals Business, the Pharma Business, and others. The majority of revenue is earned through the Pharma business.
35GF Score

Get the complete analysis for NSE:VIVIMEDLAB

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹7.07
Price
₹2.41
GF Value